Stem cell transplant in monkeys shows promise for Parkinson's

04/24/2013 | MedicalXpress.com

Researchers infused monkeys with a Parkinson's-like disease with mesenchymal stem cells that were treated with growth factors to promote development into A9 dopaminergic neurons, which become damaged in patients who have Parkinson's disease. PET scans showed monkeys treated with the cells demonstrated increased dopamine transporter expression, according to the study published in the Journal of Clinical Investigation. Researchers hope to be able to begin developing the method for use in human patients.

View Full Article in:

MedicalXpress.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX